2,021
Views
1
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

RE: Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction

, , , , &
Pages 1145-1147 | Received 30 May 2018, Accepted 16 Jul 2018, Published online: 13 Aug 2018

References

  • Liang L, Bin-Chia Wu D, Aziz MIA, et al. Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction. J Med Econ 2018;21:174-81
  • McMurray JJV, Trueman D, Hancock E, et al. Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction. Heart 2018;104:1006-13
  • Allen LA, Yager JE, Funk MJ, et al. Discordance between patient-predicted and model predicted life expectancy among ambulatory patients with heart failure. JAMA 2008;299:2533-42
  • Alter DA, Ko DT, Tu JV, et al. The average lifespan of patients discharged from hospital with heart failure. J Gen Intern Med 2012;27:1171-9
  • Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programme. Third edition. Oxford, UK: Oxford University Press; 2005
  • Siebert U, Alagoz O, Bayoumi AM, et al. State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3. Value Health 2012;15:812-20
  • Drug Evaluation Methods and Process Guide, Version 1.0. Agency for Care Effectiveness. Singapore; February 2018. Available at: https://www.moh.gov.sg/content/dam/moh_web/ACE-HTA/our-process-and-methods.html [Last accessed 3 April 2018]
  • Flather MD, Shibata MC, Coats AJ, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-25
  • Packer M, McMurray JJ, Desai AS, et al. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation 2015;131:54-61
  • Canu A, et al. Results of a single center experience on 200 consecutive patients treated with Entresto (sacubitril/valsartan). Eur J Heart Fail 2017;19:413-14
  • Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49
  • Guide to the methods of technology appraisal 2013. London; 2013. Available at: https://www.nice.org.uk/process/pmg9/chapter/foreword [Last accessed 15 April 2018]
  • World Health Organization. World Health Organization, cost-effectiveness thresholds. Geneva; 2012. Available at: http://www.who.int/choice/cost-effectiveness/generalized/en/ [Last accessed May 8, 2018]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.